KARLA SCHWEIGERT: Open Payments
NPI 1568708667 · CHAMPAIGN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 50 payments from 15 companies in 2025. Trend: 2023 $1,372 · 2024 $1,357 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $218 |
| Amgen Inc. | 7 | $144 |
| Novo Nordisk Inc | 4 | $113 |
| E.R. Squibb & Sons, L.L.C. | 4 | $107 |
| Esperion Therapeutics, Inc. | 4 | $92 |
| SCPHARMACEUTICALS INC. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Boston Scientific Corporation | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Ionis Pharmaceuticals, Inc. | 2 | $55 |
Products named: LEQVIO, REPATHA, NEXLETOL, Wegovy, CAMZYOS, FUROSCIX, WATCHMAN Access System, JARDIANCE.
Industry payments across IL — which companies pay providers there.
